SENIOR JOURNAL.COM - Senior Citizens Information and News

Front Page    Search     Contact Us     Advertise in Senior Journal


SeniorJournal.com

INDEX


FRONT PAGE

PAGE TWO
More Headlines

 • General Features

 • Find Help

 • SENIOR ALERTS

 • Baby Boomers

 • Odds & Ends

Health-Fitness

 • Aging

 • Alzheimer's & Dementia

 • Fitness

 • Health/Medicine

 • Medical Research

 • Nutrition/Vitamin

Government

 • Politics

 • Medicare

 • Medicare Drug Program

 • Medicare Q&A - Dear Marci

 • Medicaid

 • Social Security

 • Social Security, Medicare Q&A

Enjoying Life

 • Books

 • Entertainment

 • Features

 • Grandparents

 • Senior Statistics

 • Senior Stars

 • Sex & Seniors

 • Sports

 • Travel

 • Senior Volunteers

On The Web

 • Links - Senior

 • Senior Friendly Business Links

 • Sites We Like

Elderly Issues

 • Elder Care

 • Assistance for Elderly

 • Housing

Money 

 • Discounts

 • Guarding Your Wealth for Seniors

 • Money Matters

 • Reverse Mortgage

 • Retirement

Thinking

 • Opinions



Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to more on Health & Medicine or More Senior News on the Front Page

 

Click here to vitamins without a pill.


 
 

E-mail this page to a friend!

Senior Citizen Health & Medicine

Inherited Gene Found to Increase Melanoma Risk

About 7,910 Americans are expected to die of melanomas during 2006

June 30, 2006 – The most common cancer is skin cancer – melanoma. Although about half of all cases occur in people older than 56, it is unusual for a cancer to appear in so many younger people. New research by the National Cancer Institute has found a link between inherited and acquired genetic factors that dramatically increase the chance of developing a very common type of melanoma. It is information that may be of particular interest to senior citizens that need to alert their children and grandchildren.

 

Related Stories

 
 

Men Found with Prostate Cancer Rush to Judgment on Treatment

June 26, 2006 – Fear and uncertainty usually drive the initial treatment decisions by men diagnosed with prostate cancer. Seeking rapid results they make emotionally driven treatment decisions influenced by anecdote and misconception rather than consideration of clinical trial evidence, and they have no time for second opinions, indicates the new study in the August issue of CANCER, journal of the American Cancer Society. Read more...

Potential of Prostate Cancer Spread Detected Early by New Test

Test works even if surrounding lymph nodes initially appear negative

June 21, 2006 - A new prognostic test can help determine whether a prostate cancer patient will go on to have a recurrence of the disease, even if surrounding lymph nodes initially appear negative for cancer, according to a study by University of Southern California researchers. Read more...

Tiny Worm is Newest Weapon to Discover Cancer-Causing Compounds in Household Products

Helps detect virtually any potential cancer-causing chemical

June 21, 2006 – A little worm has enabled scientist to detect action that blocks "cell suicide," and causes chemical compounds in household products, like mothballs and air fresheners, to because possible cancer-causing agents. It is the first systematic way to screen virtually any potential cancer-causing chemical that may affect humans, according to the study spearheaded by the University of Colorado at Boulder. Read more...


Read more on Health & Medicine

 

This finding appears in an online version of Science on June 29, 2006, and was a collaborative effort led by scientists at NCI, part of the National Institutes of Health, and the University of California San Francisco. Also involved in the study were researchers at the University of Pennsylvania, Philadelphia, and Bufalini Hospital in Cesena, Italy.

“Knowing who is at greater risk for melanoma due to heredity, and understanding the pathways leading to cancer, are important steps in addressing a disease which is expected to be diagnosed in over 62,000 Americans in 2006,” said National Institutes of Health Director Elias A. Zerhouni, M.D.

People with fair skin are generally at increased risk of developing melanoma. Differences in skin color, or pigmentation, are due largely to the melanocortin-1 receptor (MC1R) gene. Everyone has two copies of MC1R; one inherited from the mother and one from the father, and either can be the standard form or a variant. Some variant forms of MC1R are responsible for traits such as fair skin, freckling, and red hair. But MC1R may do much more than influence pigmentation.

“We previously observed that subjects who inherit one or two variant forms of the MC1R gene had a modest increase in risk of developing melanoma, even if they have darker pigmentation,” said Maria Teresa Landi, M.D., Ph.D., lead study investigator at NCI. “We have now discovered that MC1R dramatically predisposes individuals with no excessive sun exposure and variable pigmentation to developing a particular type of melanoma.”

Melanomas, which are tumors that arise from cells which produce skin pigment, can occur on all parts of the body where these cells are present. Caucasians have a much higher chance than other populations of developing these tumors on skin areas that are exposed to the sun. Sun exposure has many effects on skin, including causing chronic sun damage, with wrinkling on areas subject to high exposure over a lifetime. Sun exposure may also lead to mutations in cancer-causing genes, such as BRAF, which are frequent in melanoma.

According to Boris Bastian, M.D., University of California, San Francisco, “The relationship between BRAF mutations in melanoma and sun exposure is complex and intriguing. On the one hand, sun exposure appears necessary for development of BRAF mutations; melanomas on areas such as the soles of feet and palms of hands, which have low exposure, have low mutation frequencies compared to the approximately 60 percent mutation frequency in sun-induced melanomas on skin without chronic sun damage.

 

Key Melanoma Statistics

 
 

By American Cancer Society

Cancer of the skin is the most common of all cancers, probably accounting for more than 50% of all cancers. Melanoma accounts for about 4% of skin cancer cases but causes a large majority of skin cancer deaths.

Melanoma tends to occur at a younger age than most cancers. Half of all melanomas are found in people under age 57. Adolescents can have melanoma also. About 1 of every 30,000 girls aged 15 to 19 will develop melanoma. For boys of this age, the rate is about 1 of every 15,000.

The American Cancer Society estimates that about 62,190 new melanomas will be diagnosed in the United States during 2006. The number of new melanomas diagnosed in the United States is increasing. Among white men and women in the United States, incidence rates for melanoma increased sharply at about 6% per year from 1973 until the early 1980s. Since 1981, however, the rate of increase slowed to little less than 3% per year. For the last 2 years in which there is information, this increase may have slowed even further.

About 7,910 people in the United States are expected to die of melanomas during 2006. Since 1973, the mortality rate for melanoma has increased by 50%. Much of this increase has been in older people, mostly white men. More recently, the death rate from melanoma has leveled off for men and dropped slightly in women.

>> More at American Cancer Society

 

On the other hand, melanomas developing in older subjects with sufficient accumulated sun exposure to produce chronic damage also exhibit lower BRAF mutation frequencies.”

Because melanomas on skin areas with few signs of chronic sun-induced damage occur in younger people and exhibit frequent mutations in BRAF, the researchers hypothesized that there were inherited genetic factor(s) that predispose to the development of these melanomas with BRAF mutations. An interesting candidate for this genetic risk factor was the MC1R gene.

To determine if there was an association between inherited variant forms of MC1R and the development of BRAF-mutant melanoma, the researchers studied the skin surrounding the melanomas in 85 patients from the Bufalini Hospital of Cesena, Italy, and 112 patients from the Department of Dermatology at the University of California, San Francisco, and identified subjects with no or little signs of chronic sun damage. They then sequenced MC1R genes in normal cells and BRAF in tumor cells and found that BRAF mutations were more frequent in non-chronic sun-induced melanoma cases with hereditary genetic variant forms of MC1R.

By categorizing patients into two groups, those with no variant forms of MC1R versus those who had at least one variant, the scientists found that BRAF mutations were six to 13 times more frequent in those with at least one MC1R variant form. Looking more closely, the investigators found that the risk for melanoma with BRAF mutations rose with increasing number of MC1R variant forms. Comparing data from melanoma patients and healthy controls, the risk for melanomas with BRAF mutations increased from seven times for individuals with one MC1R variant form, to 17 times for those with two variant forms, when compared with individuals with the standard MC1R.

The study results show that normal variations in the MC1R gene in Caucasians have a very specific effect on melanoma susceptibility. Additional inherited factors that affect susceptibility may also be present, but they have yet to be discovered. “The mechanism by which variant forms of the MC1R gene facilitate development of melanomas with BRAF mutations is currently unknown,” said Landi.

“One possibility is that people with MC1R variant forms and variable pigmentation generate more reactive chemicals in their cells as a result of the ultraviolet exposure in sunlight. These reactive chemicals can induce mutations, like those in the BRAF gene, which may lead to cancer.”

Clinical trials for melanoma using pharmaceutical drugs directed against the BRAF gene are ongoing. Knowledge of predisposing factors in the development of BRAF mutations, such as MC1R, might aid prevention and therapeutic strategies in the future.

For more information about cancer, please visit the NCI Web site at http://www.cancer.gov, or call NCI’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

 

 

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

    

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.